The Net Margin of Tibet Rhodiola Pharmaceutical Holding Co (600211.SS) is 25.55%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2023-12-31 | 25.55% |
| 2022-12-31 | 14.48% |
| 2021-12-31 | 9.77% |
| 2020-12-31 | 30.45% |
| 2019-12-31 | 24.86% |
| 2018-12-31 | 20.97% |
| 2017-12-31 | 25.08% |
| 2016-12-31 | 24.89% |
| 2015-12-31 | 6.62% |
| 2014-12-31 | 1.26% |